Inventor · disambiguated record
Dominique Bonnet
Also filed as: BONNET DOMINIQUE
12 granted patents·10 pending applications·161 citations·filing 1998–2022
92Inventor score
Top patents by PatentIndex Score
22 records- 0193US10155049B2Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2016·Granted Dec 18, 2018·12 cites·15 claims
- 0293US7687455B2Antigen delivery vectors and constructsIMMUNE TARGETING SYSTEMS LTD·Filed 2005·Granted Mar 30, 2010·38 cites·28 claims
- 0391US8129333B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2008·Granted Mar 6, 2012·13 cites·25 claims
- 0491US8110541B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2010·Granted Feb 7, 2012·12 cites·14 claims
- 0591US8110540B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2010·Granted Feb 7, 2012·13 cites·19 claims
- 0690US8759281B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2012·Granted Jun 24, 2014·11 cites·22 claims
- 0789US8642531B2Influenza antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2008·Granted Feb 4, 2014·10 cites·33 claims
- 0887US9446143B2Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2013·Granted Sep 20, 2016·8 cites·10 claims
- 0985US11066353B2Antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2014·Granted Jul 20, 2021·2 cites·19 claims
- 1077US2022073446A1Antigen Delivery Vectors and ConstructsALTIMMUNE UK LTD·Filed 2021·Application pending·0 cites
- 1170US6304273B1Process for depicting paths within a graphical representation of a networkFRANCE TELECOM·Filed 1998·Granted Oct 16, 2001·40 cites·3 claims
- 1267US7390875B2Method for binding, in solution, a peptide and a lipophilic vector and uses thereofPASTEUR INSTITUT·Filed 2001·Granted Jun 24, 2008·2 cites·27 claims
- 1365US2021316000A9Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2018·Application pending·0 cites
- 1460US2023173076A1Metabolically stable peptide analogsUNIV STRASBOURG·Filed 2022·Application pending·0 cites
- 1558US2021206817A1Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin ReceptorINSERM INSTITUT NATIONAL SANTE ET DE LA RECH MEDICALE·Filed 2021·Application pending·0 cites
- 1645US2023174480A1Fluorogenic dimer compound, useful as a probe for detection of endogenous receptorsUNIV STRASBOURG·Filed 2021·Application pending·0 cites
- 1744US2002098521A1Method and marker for the isolation of human multipotent hematopoietic stem cellsFiled 2001·Application pending·0 cites
- 1843US2019328887A1Metabolically stable peptide analogsUNIV STRASBOURG·Filed 2017·Application pending·0 cites
- 1941US2009170749A1Novel Compounds Which Interact With PEA-15INST NAT SANTE RECH MED·Filed 2006·Application pending·0 cites
- 2038US2017355734A1Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin ReceptorINSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2015·Application pending·0 cites
- 2136US2019135887A1Metabolically stable spexin peptide analogsUNIV STRASBOURG·Filed 2017·Application pending·0 cites
- 2233US11046657B2Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokinesCENTRE NAT RECH SCIENT·Filed 2017·Granted Jun 29, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Dominique Bonnet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →